Faculty of Bioresources and Environmental Science, Ishikawa Prefectural University, Nonoichi, Ishikawa, 921-8836, Japan.
Showa Pharmaceutical University, Machida, Tokyo, 194-8543, Japan.
J Nat Med. 2021 Jan;75(1):194-200. doi: 10.1007/s11418-020-01449-y. Epub 2020 Sep 24.
The production and accumulation of advanced glycation end products (AGEs) have been implicated in diabetes and diabetic complication. This study was conducted as a search for an AGE inhibitor from brown alga, Sargassum macrocarpum. Separation and purification were performed using AGEs inhibitory activity as an index, yielding isolation of 11 meroterpenoids, of which 3 were new compounds: macrocarquinoids A (1), B (6), and C (9). Their structures were elucidated using NMR spectral analysis with 2D techniques. All tested compounds showed AGEs inhibitory activity. Particularly, macrocarquinoid C (9) possessed the strongest activity (IC: 1.0 mM) of isolated compounds. This activity was stronger than that of aminoguanidine (positive control).
先进糖基化终产物(AGEs)的产生和积累与糖尿病及其并发症有关。本研究从褐藻马尾藻中寻找 AGE 抑制剂。采用 AGEs 抑制活性为指标进行分离纯化,得到 11 种倍半萜类化合物,其中 3 种为新化合物:macrocarquinoids A(1)、B(6)和 C(9)。通过 NMR 谱分析结合二维技术确定了它们的结构。所有测试的化合物都表现出 AGEs 抑制活性。特别是,macrocarquinoid C(9)具有最强的活性(IC:1.0 mM)。该活性强于氨基胍(阳性对照)。